MUMBAI, India – November 27, 2025 – Borosil Scientific Limited (BSE: 544184, NSE: BOROSCI), a leading Indian manufacturer of scientific and laboratory glassware, has announced a significant strategic investment in its subsidiary, Goel Scientific Glass Works Limited. The move, disclosed in a regulatory filing to the stock exchanges, underscores the company’s commitment to strengthening its core manufacturing operations.
In a letter dated November 27, 2025, addressed to the BSE Limited and The National Stock Exchange of India Limited, the company’s Board, through Company Secretary Mr. Sanjay Gupta, intimated a further investment in Goel Scientific via a rights issue.
Key Transaction Details
The investment, classified as a Related Party Transaction conducted at an arm’s length, involves a cash consideration of ₹11,68,15,570 (approx. ₹11.68 Crore). This capital infusion will be used to subscribe to 1,16,81,557 equity shares of Goel Scientific at a face value of ₹10 per share.
Following the completion of this rights issue, Borosil Scientific’s shareholding in its subsidiary will increase substantially, from its current level to 99.37%, cementing its control over one of India’s oldest and most skilled scientific glassware manufacturers.
Strategic Rationale and Objectives
According to the annexure filed with the exchange, the primary objective of this capital infusion is to enable Goel Scientific to meet its capital expenses, operational expenses, and other general corporate purposes. This investment is squarely within Borosil Scientific’s main line of business, aimed at bolstering the production capabilities and financial health of a key subsidiary.
Profile of Goel Scientific Glass Works Limited
Goel Scientific, incorporated in 1998 and based in Vadodara, Gujarat, is a significant player in the niche manufacturing sector of Industrial Glass Process Systems and Laboratory Glassware. The company is renowned for its highly skilled glass-blowing capabilities and has a global footprint, with a presence in Europe, North America, the Middle East, and across Asia.
Financial Performance (Turnover):
The company has demonstrated a variable financial performance over the last three fiscal years, as reported by Borosil Scientific:
- FY 2024-25: ₹4,928.08 Lakhs
- FY 2023-24: ₹4,415.18 Lakhs
- FY 2022-23: ₹6,129.88 Lakhs (restated)
This investment is expected to provide Goel Scientific with the necessary capital to stabilize and potentially grow its turnover in the competitive global market.
Market Implications and Outlook
This transaction is a clear indicator of Borosil Scientific’s strategy to consolidate and strengthen its position in the scientific glassware industry by directly funding the growth of its core subsidiary. For investors, this move signals management’s confidence in the long-term prospects of its manufacturing ecosystem and its commitment to funding internal growth initiatives.
https://nsearchives.nseindia.com/corporate/BOROSCI_27112025125921_BSLInvestsigned.pdf
Useful Websites for Investors
For comprehensive financial and market information, investors are advised to refer to official sources:
Disclaimer
Not a SEBI Registered Analyst
I am not a SEBI Registered Investment Adviser or Research Analyst. All information shared is for educational and informational purposes only and is not intended as a substitute for professional financial advice. All opinions expressed herein are based on my personal observations and research. They do not constitute a recommendation or a solicitation to buy, sell, or hold any security. Investments in the securities market are subject to market risks. The value of investments may go up or down. Past performance is not indicative of future results.
You are solely responsible for your own investment decisions. You should conduct your own research and consult with a qualified financial advisor before making any investment based on the information provided here.
I may or may not hold positions in the securities mentioned. This is a personal blog/platform, and I have no relationship with the companies mentioned unless explicitly stated.